CSPC Innovation(SZ:300765) Xin Lang Cai Jing·2025-10-23 02:13Company Overview - XinNuoWei is primarily engaged in the research, production, and sales of functional foods, with 88.93% of its revenue coming from this segment, followed by biopharmaceuticals at 8.91% and other sources at 2.16% [1] - The company was established on April 5, 2006, and went public on March 22, 2019 [1] Stock Performance - As of October 23, XinNuoWei's stock price decreased by 2.03%, trading at 40.11 CNY per share, with a market capitalization of 56.338 billion CNY [1] - Year-to-date, the stock has increased by 50.96%, but has seen declines of 8.28% over the last five trading days, 17.09% over the last 20 days, and 23.01% over the last 60 days [1] Financial Performance - For the first half of 2025, XinNuoWei reported revenue of 1.05 billion CNY, a year-on-year increase of 7.99%, while the net profit attributable to shareholders was a loss of 2.7461 million CNY, a decrease of 102% compared to the previous year [2] Shareholder Information - As of October 20, XinNuoWei had 16,400 shareholders, a decrease of 2.77% from the previous period, with an average of 75,892 circulating shares per shareholder, an increase of 2.85% [2] - The company has distributed a total of 651 million CNY in dividends since its A-share listing, with 500 million CNY distributed over the last three years [3] Institutional Holdings - As of June 30, 2025, the second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 20.9991 million shares, an increase of 5.045 million shares from the previous period [3] - New institutional shareholders include Zhongou Medical Innovation Stock A and Huatai-PineBridge Innovation Medical Mixed A, while others like E Fund Healthcare Industry Mixed A have exited the top ten circulating shareholders list [3]